# A Retrospective Analysis of Suramin Treatment for Stage 1 TBR

> **NCT06060600** · — · COMPLETED · sponsor: **Paxmedica** · enrollment: 345 (actual)

## Conditions studied

- Trypanosoma Brucei Rhodesiense; Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06060600
- **Lead sponsor:** Paxmedica
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-02
- **Primary completion:** 2023-08-02
- **Final completion:** 2023-08-02
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06060600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06060600, "A Retrospective Analysis of Suramin Treatment for Stage 1 TBR". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06060600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*